Baxter International Inc. | Income Statement

Fiscal year is January-December. All values USD Millions.
2013
2014
2015
2016
2017
2018
Sales/Revenue
15,260
10,718
9,968
10,163
10,561
11,127
Cost of Goods Sold (COGS) incl. D&A
7,472
6,098
5,859
5,860
5,980
6,282
Gross Income
7,788
4,620
4,109
4,303
4,581
4,845
SG&A Expense
4,542
3,793
3,496
3,154
3,097
3,069
EBIT
3,246
-
-
1,149
1,484
1,776
Unusual Expense
672
93
325
3,825
241
131
Non Operating Income/Expense
12
30
223
55
26
97
Interest Expense
109
236
103
98
82
97
Pretax Income
2,518
490
428
4,954
1,217
1,693
Income Tax
537
33
35
12
493
63
Consolidated Net Income
1,981
457
393
4,966
724
1,630
Net Income
2,012
457
393
4,966
724
1,630
Net Income After Extraordinaries
2,012
1,583
182
4,967
731
1,636
Net Income Available to Common
2,012
2,497
968
4,946
715
1,624
EPS (Basic)
3.66
4.56
1.76
9.01
1.29
2.97
Basic Shares Outstanding
543
542
545
546
543
534
EPS (Diluted)
3.66
4.56
1.76
9.01
1.29
2.97
Diluted Shares Outstanding
549
547
549
551
555
546
EBITDA
4,069
1,619
1,372
1,901
2,235
2,552
Non-Operating Interest Income
17
22
20
23
30
48
Minority Interest Expense
31
-
-
-
-
-
Equity in Affiliates (Pretax)
24
-
-
-
-
-

About Baxter International

View Profile
Address
One Baxter Parkway
Deerfield Illinois 60015
United States
Employees -
Website http://www.baxter.com
Updated 07/08/2019
Baxter International, Inc. provides a broad portfolio of essential renal and hospital products, including acute and chronic dialysis, sterile IV solutions, infusion systems and devices, parenteral nutrition therapies; premixed and oncolytic injectable, bio surgery products and anesthetics, drug reconstitution systems; and pharmacy automation, software and services. It operates through the following segment: Americas, Europe, Middle East & Africa and Asia-Pacific. The company was founded by Davis Baxter in 1931 and is headquartered in Deerfield, IL.